Tian-Cheng Wang
Children's Hospital of Philadelphia(US)Central South University(CN)Second Xiangya Hospital of Central South University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Inflammatory Biomarkers in Disease Prognosis, Liver Disease Diagnosis and Treatment, Renal cell carcinoma treatment, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Multihydroxylated [Gd@C82(OH)22]n Nanoparticles: Antineoplastic Activity of High Efficiency and Low Toxicity(2005)299 cited
- → De novo loss-of-function variants in X-linked MED12 are associated with Hardikar syndrome in females(2020)33 cited
- → Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE(2021)30 cited
- → DDX24 promotes metastasis by regulating RPL5 in non‐small cell lung cancer(2022)15 cited
- → Development and Validation of a Predictive Model for Early Refractoriness of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma(2021)12 cited
- → CD36-mediated accumulation of MDSCs exerts abscopal immunosuppressive responses in hepatocellular carcinoma after insufficient microwave ablation(2024)10 cited